Abstract

Introduction/BackgroundBrain metastases (BMs) are rare sites of ovarian cancer (OC) recurrence, associated with poor prognosis. While the genomic landscape of primary OC has been well described, genomic alterations characterizing BM...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call